Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation

Newman, 2009, Treatment of inflammatory diseases with mesenchymal stem cells, Inflamm Allergy Drug Targets, 8, 110, 10.2174/187152809788462635

Renner, 2009, Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function, Transplant Proc, 41, 2607, 10.1016/j.transproceed.2009.06.119

Polchert, 2008, IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease, Eur J Immunol, 38, 1745, 10.1002/eji.200738129

Prasanna, 2010, Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially, PLoS One, 5, e9016, 10.1371/journal.pone.0009016

Ren, 2009, Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression, Stem Cells, 27, 1954, 10.1002/stem.118

Francois, 2012, Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation, Mol Ther, 20, 187, 10.1038/mt.2011.189

Raffaghello, 2008, Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche, Stem Cells, 26, 151, 10.1634/stemcells.2007-0416

Najar, 2009, Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6, Cytotherapy, 11, 570, 10.1080/14653240903079377

Rasmusson, 2007, Mesenchymal stem cells stimulate antibody secretion in human B cells, Scand J Immunol, 65, 336, 10.1111/j.1365-3083.2007.01905.x

Crop, 2010, Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation, Stem Cells Dev, 19, 1843, 10.1089/scd.2009.0368

Tokoyoda, 2010, Organization of immunological memory by bone marrow stroma, Nat Rev Immunol, 10, 193, 10.1038/nri2727

Glennie, 2005, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, 105, 2821, 10.1182/blood-2004-09-3696

Benvenuto, 2007, Human mesenchymal stem cells promote survival of T cells in a quiescent state, Stem Cells, 25, 1753, 10.1634/stemcells.2007-0068

Giuliani, 2011, Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation, PLoS One, 6, e19988, 10.1371/journal.pone.0019988

Zappia, 2005, Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood, 106, 1755, 10.1182/blood-2005-04-1496

Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871

Cutler, 2010, Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation, J Immunol, 185, 6617, 10.4049/jimmunol.1002239

Wang, 2010, CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells, Exp Cell Res, 316, 2414, 10.1016/j.yexcr.2010.04.018

Hof-Nahor, 2012, Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes, J Cell Sci, 125, 4640, 10.1242/jcs.108860

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin Exp Immunol, 149, 353, 10.1111/j.1365-2249.2007.03422.x

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Nemeth, 2009, Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat Med, 15, 42, 10.1038/nm.1905

Gieseke, 2010, Human multipotent mesenchymal stromal cells employ galectin-1 to inhibit immune effector cells, Blood, 116, 3770, 10.1182/blood-2010-02-270777

Batten, 2006, Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves, Tissue Eng, 12, 2263, 10.1089/ten.2006.12.2263

Jitschin, 2013, Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation, Stem Cells, 31, 1715, 10.1002/stem.1386

Rochman, 2005, IL-6 increases primed cell expansion and survival, J Immunol, 174, 4761, 10.4049/jimmunol.174.8.4761

Teague, 1997, IL-6 rescues resting mouse T cells from apoptosis, J Immunol, 158, 5791, 10.4049/jimmunol.158.12.5791

Francois, 2012, Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing, Cytotherapy, 14, 147, 10.3109/14653249.2011.623691

Croitoru-Lamoury, 2007, Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone, J Interferon Cytokine Res, 27, 53, 10.1089/jir.2006.0037

Liu, 2011, Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer, J Biol Chem, 286, 25007, 10.1074/jbc.M110.213108

Mulley, 2008, Indoleamine 2,3-dioxygenase in transplantation, Nephrology, 13, 204, 10.1111/j.1440-1797.2007.00921.x

Krampera, 2011, Mesenchymal stromal cell ‘licensing’: a multistep process, Leukemia, 25, 1408, 10.1038/leu.2011.108

Yanez, 2006, Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease, Stem Cells, 24, 2582, 10.1634/stemcells.2006-0228

Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X

Chang, 2013, Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury, PLoS One, 8, e52419, 10.1371/journal.pone.0052419